Synthesis, Crystal Structure and DNA/BSA Interaction of a Ni(Ⅱ) Coordination Compound

[1] Pages B J, Ang D L, Wright E P, et al. Dalton Transactions, 2015, 44: 3505.

[2] Wang K H, Gao E J. Anti-Cancer Agents in Medicinal Chemistry, 2014, 14: 147.

[4] Brabec V, Hrabina O, Kasparkova J. Coordination Chemistry Reviews, 2017, 351(15): 2.

[5] Amable L. Pharmacological Research, 2016, 106, 27.

[7] Golovnev N N, Molokeev M S, Sterkhova I V, et al. Journal of Coordination Chemistry, 2016, 21: 3219.

[8] Golovnev N N, Molokeev M S, Vereshchagin S N, et al. Journal of Coordination Chemistry, 2015, 11: 1865.

[9] Wang C, Zhou M S, Yang L J, et al. Chinese Journal of Structural Chemistry, 2017, 36(7): 1210.

[10] Sheldrick G M. Acta Crystallographica Section C, 2015, C71: 3.

[11] Dolomanov O V, Bourhis L J, Gildea R J, et al. Journal of Applied Crystallography, 2009, 42(3): 339.

[13] Wang K H, Zhu M C, Wang D L, et al. Journal of Structural Chemistry, 2015, 56(1): 191.

[14] Zhu M C, Cui X T, Zhao F C, et al. RSC Advances, 2015, 5: 47798.

[16] Hu J Y, Liao C L, Guo Y, et al. Polyhedron, 2017, 132: 28.

[17] Sathiyaraj S, Buthcer R J, Jayabalakrishnan C. Journal of Molecular Structure, 2012, 1030: 95.

[19] Lakowicz J F. Principles of Fluorescence Spectroscopy, 2nd ed. Plenum Press, New York, 1999. 237.

[20] Zhou X Q, Sun Q, Jiang L, et al. Dalton Transactions, 2015, 44: 9516.

[21] Anbazhagan V, Renganathan R. Journal of Luminescence, 2008, 128: 1454.